Colombia
- Capital: Bogotá
- Economy: free market economy. Nominal GDP US$283.109 billion
- Health Expenditure: 5.9% of GDP, 2008
- Population: 49 million, 2017
- Average Life Span: 75.2 years, 2010
- Languages: Spanish
- Adult Literacy Rate: 93%
Health Trends
Clinical Trial Landscape
- 4th largest Latin American pharmaceutical market
- 325 clinical trials to date (Phase I, II and IIIb)
- Opportunities in metabolics, hypertension and oncology
- Majority of the market is supplied by the relatively well-developed domestic industry
• To date, five national regulatory authorities have been recognised by PAHO/WHO as National Regulatory Authorities of Regional Reference, one of them being the National Institute of Food and Drug Monitory of Colombia (INVIMA).
• Clinical Investigation Sites are certified by INVIMA in GCP compliance
ICON in Colombia |
Add to Comparison Tool |
- Established in 2008
- 44 Employees, 2017
- Total awarded studies: 43 (2008 - YTD 2012), and currently participating in 20 studies in various therapeutic areas including Oncology, Diabetes, Cardiovascular, HIV, Gastric Disorders, Psoriasis and Transplants
- Majority of studies in Oncology, Cardiovascular, Metabolics and Dermatology
Services Offered
- Clinical Monitoring
- Study start-up and Feasibility
- Medical & Safety Services
- Late Phase Research (Ph IV)
- Coverage of other Central American countries (recent examples including Panama, Costa Rica & Dominican Republic)
- Logistics
- DOCS Resourcing Solutions
- Functional Resourcing
- Flexible Resourcing
- Permanent Recruitment
Contact Us for further information